A Feasibility Study to Inform the Design of a Randomized Controlled Trial to Identify the Most Clinically and Cost Effective Anticoagulation Length With Low Molecular Weight Heparin in the Treatment of Cancer Associated Thrombosis (ALICAT): Study Protocol for a Mixed-Methods Study
Trials - United Kingdom
doi 10.1186/1745-6215-15-122
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
Springer Science and Business Media LLC